Higher clinical stage, Ki67 percentage, and percentage of nodal solid component imply higher proliferation and invasiveness of tumour cells and higher risk of postoperative recurrence, which is consistent with previous reports (37–39). This evidence concerns the gene MKI67 and neoplasm.